| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/17/2007 | US20070110739 Wipe away pain |
| 05/17/2007 | US20070110738 Receptor antagonists as therapeutic agents for iNOS generating illness |
| 05/17/2007 | US20070110736 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/17/2007 | US20070110735 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/17/2007 | US20070110734 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 05/17/2007 | US20070110731 Integument Cell Regeneration Formulation |
| 05/17/2007 | US20070110728 Method for preventing and treating diabetes using dg119 |
| 05/17/2007 | US20070110724 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 05/17/2007 | US20070110723 Delivery of trefoil peptides |
| 05/17/2007 | US20070110715 Treatment of alzheimer's disease |
| 05/17/2007 | US20070110714 Medicinal composition for treatment of chronic hepatitis c |
| 05/17/2007 | US20070110713 Novel multifunctional cytokines |
| 05/17/2007 | US20070110712 Method of modulating fertility in animals |
| 05/17/2007 | US20070110711 Agent for enhancing the production of cytokines and/or chemokines |
| 05/17/2007 | US20070110710 Treatment with immunoregulatory t cells |
| 05/17/2007 | US20070110709 Water-soluble stabilized self-assembled polyelectrolytes |
| 05/17/2007 | US20070110698 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/17/2007 | US20070110685 Combination therapy for the treatment of immunoinflammatory disorders |
| 05/17/2007 | US20070110683 Oral care formulation |
| 05/16/2007 | EP1785433A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 05/16/2007 | EP1784423A1 Novel peptide and pharmaceutical composition containing said peptide |
| 05/16/2007 | EP1784418A2 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 05/16/2007 | EP1784220A2 Bacterial iron acquisition targets |
| 05/16/2007 | EP1784217A1 Treatment of hiv infection by t-cell modulation |
| 05/16/2007 | EP1784216A1 S100 protein inhibitors for treating leukemia |
| 05/16/2007 | EP1784209A1 Contraceptives based on sp22 and sp22 antibodies |
| 05/16/2007 | EP1784207A1 Ica512 couples insulin secretin and gene expression in beta cells |
| 05/16/2007 | EP1784206A2 Antimicrobial peptides derived from cap18 |
| 05/16/2007 | EP1784205A1 Stretch mark treatment with botulinum toxic |
| 05/16/2007 | EP1784203A2 Refolding transforming growth factor beta family proteins |
| 05/16/2007 | EP1784202A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 05/16/2007 | EP1784176A1 Composition comprising lactic acid and lactoferrin |
| 05/16/2007 | EP1784165A1 Stable particle formulations of erythropoietin receptor agonists |
| 05/16/2007 | EP1784160A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 05/16/2007 | EP1592439B1 Method for production of an albumin solution |
| 05/16/2007 | EP1536807A4 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/16/2007 | EP1490092B1 Cosmetic or pharmaceutical composition containing peptides |
| 05/16/2007 | EP1487981B1 Growth regulating proteins |
| 05/16/2007 | EP1465923B1 Corticotropin releasing factor receptor 2 agonists |
| 05/16/2007 | EP1458883B1 Screening method for agents useful in treating diabetes |
| 05/16/2007 | EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization |
| 05/16/2007 | EP1390406B1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/16/2007 | EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 05/16/2007 | EP1203019B1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 05/16/2007 | EP1185664B1 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | EP1147188B1 Internal ribosome entry site (ires), vector containing same and the uses thereof |
| 05/16/2007 | EP1140136B1 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 05/16/2007 | EP1129190B1 Human tslp dna and polypeptides |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/16/2007 | EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 05/16/2007 | CN1964989A Long lasting insulin derivatives and methods thereof |
| 05/16/2007 | CN1964737A Methods of using IL-1 antagonists to treat autoinflammatory disease |
| 05/16/2007 | CN1964736A Dalbavancin compositions for treatment of bacterial infections |
| 05/16/2007 | CN1964735A Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury |
| 05/16/2007 | CN1964734A Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition therefor in form of a kit |
| 05/16/2007 | CN1964733A Novel use of peptide compounds for treating essential tremor and other tremor syndromes |
| 05/16/2007 | CN1964732A Peptidic vasopressin receptor agonists |
| 05/16/2007 | CN1964731A Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 05/16/2007 | CN1964720A Transgenic models of alzheimer's disease and uses therefor in the treatment of a variety of neurodegenerative diseases |
| 05/16/2007 | CN1964698A Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 05/16/2007 | CN1964695A Topical l-carnitine compositions |
| 05/16/2007 | CN1964630A Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 05/16/2007 | CN1962866A Human SCARA5 gene, its coded protein and application |
| 05/16/2007 | CN1962865A Human SFRP1 gene, its coded protein and application |
| 05/16/2007 | CN1962862A Method for high-density fermentation production of recombinant earthworm fibrinolysin PI239 in yeast system and engineering bacterium therefor |
| 05/16/2007 | CN1962695A GLP-1 infusion proteins, their preparation and use |
| 05/16/2007 | CN1962693A Long-acting thymosin alpha1 polyethylene glycol modifier |
| 05/16/2007 | CN1962691A Thymus tetrapeptide active isomer and its preparation method and medicinal uses |
| 05/16/2007 | CN1962690A Oxya chinensis(Thunberg) imago antibacterial protein preparation method |
| 05/16/2007 | CN1962689A Ciona polypeptide with resistance to angiogenesis and tumour and its preparation method |
| 05/16/2007 | CN1961958A Method for improving cicatrisation of wound |
| 05/16/2007 | CN1961957A Anti-aging colon absorption preparation |
| 05/16/2007 | CN1961956A Aseptic powder injection used for breasts of cow with mastitis and preparation method thereof |
| 05/16/2007 | CN1961880A Cancer treatment. |
| 05/16/2007 | CN1961878A Streptogramin derivatives, their preparation and compositions containing them |
| 05/16/2007 | CN1961863A An anticancer sustained releasing agent containing mesenchyme hydrolytic reagent and cytotoxic drug |
| 05/16/2007 | CN1961862A Compound anticancer sustained releasing agent containing mesenchyme hydrolytic reagent |
| 05/16/2007 | CN1961861A An anticancer sustained releasing agent |
| 05/16/2007 | CN1961860A A solid tumor resistant tumor |
| 05/16/2007 | CN1316022C Novel chimeric TNF ligands |
| 05/16/2007 | CN1316021C Nerve growth factor cDNA, clone and expression of Chinese cobra |
| 05/16/2007 | CN1316019C Anti-CD 20 embedded antibody mutant gene and its use |
| 05/16/2007 | CN1315871C One kind of tumor relevant protein and its coding gene and application |
| 05/16/2007 | CN1315870C Peptide and compounds that bind to receptor |
| 05/16/2007 | CN1315869C Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine |
| 05/16/2007 | CN1315537C LIM Mineralization protein splice variants |
| 05/16/2007 | CN1315532C Compound lysoamidase spray agent and preparing method |
| 05/16/2007 | CN1315531C Remedies for dry eye and diseases associated with dry eye |
| 05/16/2007 | CN1315530C Method of preparing system for controlled release of medication in protein category |
| 05/16/2007 | CN1315517C Sucking tablet of gastrodia elata and its production method |
| 05/16/2007 | CN1315413C Compositions for appetite control and related methods |
| 05/15/2007 | US7219253 Process for providing submodel performance in a computer processing unit |
| 05/15/2007 | US7217809 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
| 05/15/2007 | US7217808 RFRP-3 and DNA thereof |
| 05/15/2007 | US7217806 Gene defective in APECED and its use |
| 05/15/2007 | US7217800 Peptide leukotriene receptor |
| 05/15/2007 | US7217795 Tumor suppressor designated TS10q23.3 |